IMCC
IM Cannabis Corp. Common Shares
Medicinal Chemicals & Botanical Products
Best Pharmaceutical Stocks 2026 →
IMCC Stock Analysis: Buy, Sell, or Hold?
$0.55
-0.02 (-3.83%)
▼
5d:
-6.81%
30d:
-59.04%
90d:
+352.91%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (77%)
Quality Score
51/100
Position
OVERSOLD
30-Day Fair Range
$0.66 – $1.54
Position: OVERSOLD
Forward P/E & Valuation
42.4x
Next 12M consensus est.
Wall Street Target
$8.22
+1386.6% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.50 / $0.86
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: IMCC shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When IMCC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: IMCC is currently trading at $0.55, which is considered oversold relative to its 30-day fair value range of $0.66 to $1.54.
Technical Outlook: Technically, IMCC is in a uptrend. Immediate support is located at $0.50, while resistance sits at $0.86. Short-term momentum is weak, with the stock down 3.8% recently.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $8.22 (+1386.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IMCC is in a uptrend. Immediate support is located at $0.50, while resistance sits at $0.86. Short-term momentum is weak, with the stock down 3.8% recently.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $8.22 (+1386.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.66 -
$1.54
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
Trading Range & Key Levels
30-Day Trading Range
$0.66 -
$1.54
Current vs Trading Range
OVERSOLD
Support Level
$0.50
Resistance Level
$0.86
Current Trend
Uptrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.8%)
- BULLISH: Trading 1386.6% below Wall St target ($8.22)
- WARNING: Composite score 51/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
42.37
Wall Street Target
$8.22
(+1386.6%)
Revenue Growth (YoY)
-40.2%
Profit Margin
-39.1%
Share IMCC Analysis
Share this live IMCC analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (IMCC)
Bearish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 5, 2026
Daily AI digest
AI Retail Discussion Summary:
IM Cannabis raised US$1.2 million in convertible note financing from an existing institutional investor. The financing comes with an option for the investor to purchase additional convertible notes and warrants.
Key Retail Themes:
Financing
Convertible Notes
Institutional Investor
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 5:42 AM ET
Data refreshes hourly during market hours. Next update: 6:42 AM
Data refreshes hourly during market hours. Next update: 6:42 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IMCC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
29 analysts |
$208 | 23 SELL |
|
ALKS
Alkermes Plc |
STRONG BUY
20 analysts |
$58 | 41 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 60 BUY |
|
TEVA
Teva Pharma Industries L… |
STRONG BUY
15 analysts |
$49 | 36 SELL |
|
HROW
Harrow Health Inc |
STRONG BUY
9 analysts |
$63 | 51 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive IMCC Research Pages
